Evaro raised $25M in a Series A round announced on January 27, 2026. A digital health startup that offers AI-powered clinical and drug prescription services for minor conditions.
A digital health startup that offers AI-powered clinical and drug prescription services for minor conditions.
Evaro, based in London, United Kingdom, announced $25M in Series A financing on January 27, 2026.
Participants include British Business Investments (BBI), Cornerstone VC, Exceptional Ventures, Simplyhealth Ventures.
Oviva provides personalized dietary advice combined with digital tools to help individuals change their habits and improve their health.
German company is a provider of targeted drug rescue program intended to involve pharmaceutical research and development.
Biotech company that offers robotic automation solutions to life sciences labs.